×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
SRRK – scholar rock holding corporation (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
SRRK
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
4/17
04:15 pm
srrk
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Low
Report
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
4/16
08:00 am
srrk
Scholar Rock to Report First Quarter 2026 Financial Results on May 7, 2026
Low
Report
Scholar Rock to Report First Quarter 2026 Financial Results on May 7, 2026
4/6
08:26 am
srrk
Scholar Rock (SRRK) Deepens SMA Manufacturing Footprint: Strategic Resilience Move or Regulatory Risk Signal? [Yahoo! Finance]
Medium
Report
Scholar Rock (SRRK) Deepens SMA Manufacturing Footprint: Strategic Resilience Move or Regulatory Risk Signal? [Yahoo! Finance]
4/1
08:41 am
srrk
Scholar Rock (SRRK) had its price target raised by Wedbush from $56.00 to $58.00. They now have an "outperform" rating on the stock.
Low
Report
Scholar Rock (SRRK) had its price target raised by Wedbush from $56.00 to $58.00. They now have an "outperform" rating on the stock.
4/1
12:11 am
srrk
Scholar Rock Resubmits Apitegromab BLA for SMA, Adds Second Fill-Finish Site; FDA Decision Eyed by Sept. [Yahoo! Finance]
Low
Report
Scholar Rock Resubmits Apitegromab BLA for SMA, Adds Second Fill-Finish Site; FDA Decision Eyed by Sept. [Yahoo! Finance]
3/31
02:24 pm
srrk
Scholar Rock Holding Corporation (SRRK) Discusses BLA Resubmission for Apitegromab in Spinal Muscular Atrophy and Regulatory Progress Transcript [Seeking Alpha]
Low
Report
Scholar Rock Holding Corporation (SRRK) Discusses BLA Resubmission for Apitegromab in Spinal Muscular Atrophy and Regulatory Progress Transcript [Seeking Alpha]
3/31
07:00 am
srrk
Scholar Rock Resubmits Biologics License Application (BLA) to FDA for Apitegromab for Treatment of Children and Adults with Spinal Muscular Atrophy (SMA)
High
Report
Scholar Rock Resubmits Biologics License Application (BLA) to FDA for Apitegromab for Treatment of Children and Adults with Spinal Muscular Atrophy (SMA)
3/29
06:45 pm
srrk
A Look At Scholar Rock Holding (SRRK) Valuation As Growth Expectations Face Mixed Share Price Signals [Yahoo! Finance]
Low
Report
A Look At Scholar Rock Holding (SRRK) Valuation As Growth Expectations Face Mixed Share Price Signals [Yahoo! Finance]
Date
Time
Symbol
Company Name
Action
%Chg
3/3/2026
07:00 am
SRRK
scholar rock holding corporation
MISS
Report
3.5%
scholar rock holding corporation
11/14/2025
07:00 am
SRRK
scholar rock holding corporation
MISS
Report
20.7%
scholar rock holding corporation
8/6/2025
07:00 am
SRRK
scholar rock holding corporation
MISS
Report
-5.2%
scholar rock holding corporation
5/14/2025
07:00 am
SRRK
scholar rock holding corporation
MISS
Report
-0.4%
scholar rock holding corporation
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
4/6
04:11 pm
srrk
Form 144 Scholar Rock Holding Filed by: Qatanani Mo
Low
Report
Form 144 Scholar Rock Holding Filed by: Qatanani Mo
3/31
07:14 am
srrk
Form 8-K Scholar Rock Holding For: Mar 31
Medium
Report
Form 8-K Scholar Rock Holding For: Mar 31
3/27
01:02 pm
srrk
Form SCHEDULE 13G/A Scholar Rock Holding Filed by: VANGUARD GROUP INC
Low
Report
Form SCHEDULE 13G/A Scholar Rock Holding Filed by: VANGUARD GROUP INC
3/3
04:36 pm
srrk
Form 8-K/A Scholar Rock Holding For: Mar 03
Medium
Report
Form 8-K/A Scholar Rock Holding For: Mar 03
3/3
07:17 am
srrk
Form 10-K Scholar Rock Holding For: Dec 31
Medium
Report
Form 10-K Scholar Rock Holding For: Dec 31
3/3
07:14 am
srrk
Form 8-K Scholar Rock Holding For: Mar 03
Medium
Report
Form 8-K Scholar Rock Holding For: Mar 03
2/25
05:55 pm
srrk
Form 4 Scholar Rock Holding For: Feb 23 Filed by: Qatanani Mo
Medium
Report
Form 4 Scholar Rock Holding For: Feb 23 Filed by: Qatanani Mo
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
3/26
Scholar Rock Announces Publication in Science Translational Medicine of Preclinical Data Detailing a Potent and Selective Inhibitor of TGFß1 Overcoming Primary Resistance to Checkpoint Inhibition
15.1%
11/19 Form 8-K Scholar Rock Holding For: Nov 19 14.6%
12/20 Form 4 Scholar Rock Holding For: Dec 17 Filed by: Moore Erin 8.6%
9/4 Scholar Rock to Present at Upcoming Healthcare Conferences 8.0%
5/14 Q1/2019 3/31/2019 EPS -0.420 ZacksConsensus N/A ActVsEst N/A - N/A 6.8%
5/15 Form 10-Q Scholar Rock Holding For: Mar 31 5.3%
7/2 Scholar Rock Announces Exercise in Full of Underwriters’ Option to Purchase Additional Shares of Common Stock in Public Offering 4.2%
8/21 Scholar Rock Holding Corp (NASDAQ: SRRK) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. 4.1%
8/14 Q2/2019 6/30/2019 EPS -0.480 ZacksConsensus -0.410 ActVsEst (0.070) - Miss 3.8%
3/12 Scholar Rock Reports Full Year 2019 Financial Results and Highlights Business Progress 3.5%
11/19 Form 8-K Scholar Rock Holding For: Nov 19 14.6%
12/20 Form 4 Scholar Rock Holding For: Dec 17 Filed by: Moore Erin 8.6%
9/4 Scholar Rock to Present at Upcoming Healthcare Conferences 8.0%
5/14 Q1/2019 3/31/2019 EPS -0.420 ZacksConsensus N/A ActVsEst N/A - N/A 6.8%
5/15 Form 10-Q Scholar Rock Holding For: Mar 31 5.3%
7/2 Scholar Rock Announces Exercise in Full of Underwriters’ Option to Purchase Additional Shares of Common Stock in Public Offering 4.2%
8/21 Scholar Rock Holding Corp (NASDAQ: SRRK) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. 4.1%
8/14 Q2/2019 6/30/2019 EPS -0.480 ZacksConsensus -0.410 ActVsEst (0.070) - Miss 3.8%
3/12 Scholar Rock Reports Full Year 2019 Financial Results and Highlights Business Progress 3.5%
TOP News Decliners
6/19
Scholar Rock to Present at the 2019 BMO Prescriptions for Success Healthcare Conference
-15.4%
6/19 Scholar Rock Announces Pricing of Public Offering of Common Stock -14.1%
3/24 Scholar Rock Holding Corp (NASDAQ: SRRK) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $17.00 price target on the stock. -8.5%
8/31 Scholar Rock Holding Corp (NASDAQ: SRRK) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. -8.3%
2/26 Scholar Rock to Present at the Cowen 40th Annual Healthcare Conference -8.3%
2/10 Form 4 Scholar Rock Holding For: Feb 06 Filed by: Moore Erin -8.1%
9/23 Form 8-K Scholar Rock Holding For: Sep 17 -7.8%
6/3 Scholar Rock Announces Positive Final Results from Phase 1 Clinical Trial of SRK-015 in Healthy Volunteers -7.5%
1/13 Form 8-K Scholar Rock Holding For: Jan 13 -6.1%
9/13 Scholar Rock Holding Corp (NASDAQ: SRRK) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $14.00 price target on the stock. -5.9%
6/19 Scholar Rock Announces Pricing of Public Offering of Common Stock -14.1%
3/24 Scholar Rock Holding Corp (NASDAQ: SRRK) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $17.00 price target on the stock. -8.5%
8/31 Scholar Rock Holding Corp (NASDAQ: SRRK) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. -8.3%
2/26 Scholar Rock to Present at the Cowen 40th Annual Healthcare Conference -8.3%
2/10 Form 4 Scholar Rock Holding For: Feb 06 Filed by: Moore Erin -8.1%
9/23 Form 8-K Scholar Rock Holding For: Sep 17 -7.8%
6/3 Scholar Rock Announces Positive Final Results from Phase 1 Clinical Trial of SRK-015 in Healthy Volunteers -7.5%
1/13 Form 8-K Scholar Rock Holding For: Jan 13 -6.1%
9/13 Scholar Rock Holding Corp (NASDAQ: SRRK) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $14.00 price target on the stock. -5.9%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: